throbber
Editor: Donna Balado
`Managing Editor: Jennifer Schmidt
`Marketing Manager: Christine Kushner
`
`Copyright © 1999 LippincottW1lliams & Wflkins
`351 West Camden Street
`Baltimore, Maryland 21201-2436 USA
`
`227 East Washington Square
`Philadelphia, PA 19106
`
`All rights reserved. This book is protected by copyright. No part of this book may be re-
`produced in any form or by any means, including photocopying, or utilized by any infor-
`mation storage and retrieval system without written permission from the copyright owner.
`
`The publisher is not responsible (as a matter of product liability, negligence, or otherwise)
`for any injury resulting from any material contained herein. This publication contains in-
`formation relating to general principles of medical care which should not be construed as
`specific instructions for individual patients. Manufacturers’product information and pack-
`age inserts should be reviewed for current information, including contraindications,
`dosages, and precautions.
`
`Printed in the United States ofAmerica
`
`Library of Congress Cataloging-in-Publication Data
`
`Ansel, Howard C., 1933-
`Pharmaceutical dosage forms and drug delievery systems / Howard C.
`Ansel, LoydV. Allen, ]r., Nicholas G. Popovich. —— 7th ed.
`p.
`cm.
`Includes bibliographical references and index.
`ISBN 0—683—30572—7
`2. Drug delivery systems.
`1. Drugs—-Dosage forms.
`Il. Popovich, Nicholas G.
`Ill Title.
`[DNLM: 1. Dosage Forms.
`2. Drug Delivery Systems. QV 785 A618i 1999]
`RS200.A57
`1999
`615’.1—dc21
`DNLM/DLC
`for Library of Congress
`
`1. Allen, LoydV.
`
`99-17498
`CIP
`The publishers have made every efiort to trace the copyright holders for borrowed material. Ifthey
`have inadvertently overlooked any, they will be pleased to make the necessary arrangements at
`the first opportunity.
`
`The use of portions of the text of USP23/NF18, copyright 1994, is by permission of the USP
`Convention, Inc.The Convention is not responsible for any inaccuracy of quotation or for
`any false or misleading implication that may arise from separation of excerpm from the
`original context or by obsolescence resulting from publication of a supplement.
`
`To purchase additional copies of this book call our customer service department at (800)
`638-3030 or fax orders to (301) 824-7390. International customers should call (301)
`714-2324.
`
`99 00 01 O2
`1 2 3 4 5 6 7 8 9 10
`
`Astrazeneca Ex. 2096 p. 2
`
`

`
`
`
`Contents
`
`Preface
`
`Acknowledgments
`
`Section I. PRINCIPLES OF DOSAGE FORM DESIGN AND DEVELOPMENT
`
`I
`
`2
`
`3
`
`4
`
`5
`
`Introduction to Drugs and Pharmacy
`
`New Drug Development and Approval Process
`
`Dosage Form Design: Pharmaceutic and
`Formulation Considerations
`
`Dosage Form Design: Biopharrnaceutic and
`Pharmacokinetic Considerations
`
`Current Good Manufacturing Practices and Good
`Compounding Practices
`
`Section II. SOLID DOSAGE FORMS AND MODIFIED-RELEASE DRUG DELIVERY SYSTEMS
`
`6
`
`7
`
`8
`
`Powders and Granules
`
`Capsules and Tablets
`
`Modified~Release Dosage Forms and Drug Delivery Systems
`
`Section III. SEMI-SOLID AND TRANSDERMAL SYSTEMS
`
`_
`
`9
`
`TO
`
`Ointments, Creams, and Gels
`
`Transdermal Drug Delivery Systems
`
`v
`
`vii
`
`1
`
`23
`
`60
`
`101
`
`142
`
`164
`
`179
`
`229
`
`‘244
`
`263
`
`ix
`
`Astrazeneca Ex. 2096 p. 3
`
`

`
`X
`
`Contents
`
`Section IV. PHARMACEUTICAL INSERTS
`
`II
`
`Suppositories and Inserts
`
`Section V.
`
`LIOUID DOSAGE FORMS
`
`I 2
`
`I3
`
`Solutions
`
`Disperse Systems
`
`Section VI. STERILE DOSAGE FORMS AND DELIVERY SYSTEMS
`
`T4
`
`T5
`
`T6
`
`Parenterals
`
`Biologicals
`
`Ophthalmic Solutions and Suspensions
`
`Section VII. NOVEL AND ADVANCED DOSAGE FORMS, DELIVERY SYSTEMS, AND DEVICES
`
`Radiopharmaceuticals
`
`Products of Biotechnology
`
`Novel Dosage Forms and Drug Delivery Technologies
`
`Systems and Techniques of Pharmaceutical Measurement
`
`T7
`
`T8
`
`T9
`
`Appendix
`
`Index
`
`279
`
`296
`
`346
`
`397
`
`450
`
`469
`
`487
`
`503
`
`535
`
`552
`
`563
`
`Astrazeneca Ex. 2096 p. 4
`
`

`
`Section V. Liquid Dosage Forms
`
`
`
`SOLUTIONS
`
`
`
`Chapter af a Glance
`
`Solubility
`Inorgmic Molecules
`Organic Molecules
`Some Solvents For Liquid Preparations
`Distillation Method
`
`Ion-exchange method
`Reverse Osmosis
`
`Preparation of Solutions
`Oral Solutions and Preparations for Oral
`Solution
`
`Dry Mfxturesfar Solution
`Oral Solutions
`
`Oral Rehycirotion Solutions
`Oral Colonic Lavage Solution
`Mogrrosium Citrate Om! Solution
`Sodium Citrate and Citric Acid Oral Solution
`
`Syrups
`Components of Syrups
`Sucrose and Nor:~Sucroso Boson‘ Syrups
`Antimicrobial Preseroatioe
`Flooormu
`Colo:-out
`Preparation of Syrups
`Solution with the Aid of.l-loot
`Solution by Agitation zoithout the Aid of
`Heat
`
`Addition of Sucrose to o Medicated Liquid or
`to o Flavored Liquid
`Percolation
`Elixirs
`
`Preparation of Elixirs
`Norunedicated Elixirs
`Medicated Elixirs
`Autihistomioe El:‘xirs
`
`Bo:-lriturote Sedotioe/Hypnotic Elixirs
`Phenobarbital Elixir
`
`Digoxin Elixir
`Tinctures
`
`295
`
`Proper Administration and Use of Liquid
`Peroral Dosage Forms
`Topical Solutions and Tinctures
`Topical Solutions
`Sprays
`Aluminum Acetate Topical Solution
`Aluminum Subocotaie Topical
`Solution
`
`Calcium Hydroxide Topical Solution
`Cool Tor Topical Solution
`Hydrogen Peroxide Topical Solution
`Chlorhexidine Glut-onote Solution
`
`Pooidorwlodine Topical Solution
`Thfmerosol Topical Solution
`Vaginal and Rectal Solutions
`Vaginal Douohes
`Retention Enemos
`Eoocuation Eoemos
`
`Topical Tinctures
`Iodine Tiucture
`
`Compound Benzoin Tiucture
`Thiroerosal Tiucture
`
`Special Application Solutions
`Nasal Preparations
`Nasal Decougostonr Solutions
`Inhalation Solutions
`
`Examples of Medicated lnholotion
`Solutions
`Iuholonis
`
`Amyl Nitrite lrrlzolarzt
`Propylhexedriue Irrluzlont
`Proper Administration and use of Nasal
`Drops and Sprays
`Nosol Routefor Systemic Eflkcfs
`Otic Solutions
`
`Cerumen-Removing Solutions
`Anti-infective, Anti-inflammatory, and
`Analgesic Ear Preparations
`
`Astrazeneca Ex. 2096 p. 5
`
`

`
`Solutions
`
`29'?’
`
`Proper Administration and Use of Otis
`Drops
`Topical Oral (Dental) Solutions.
`Miscellaneous Solutions
`Ar-omaticwalaers
`Diluted Acids
`.
`_
`Spirits
`_
`Nonequeoussolut-.-one
`
`Lmrrne’'
`nts
`Collodions
`Callodian
`
`Flexible Colladion
`Salicylic Acid Collodion
`Extraction Methods for Preparing
`Sohrfioris
`Methods of Exn-action
`Msceratian
`Percolation
`
`Example Preparations Prepared by
`Extraction Processes
`Pluidextracts
`Extracts
`
`INPm'5!COCl-mvltCA.Lteru1s,solulior1s maybe pre-
`pared from any corobination of solid, liquid, and
`gas, the threestares of matter. For example, a solid
`solute may be dissolved in either another solid, as
`oragas, andwitlrthesarrnebeirigtrue flora
`liquid solute and for a gas. nine types of ho.1:noge-
`neous mixtures arepossible In pharmacy. however.
`interest insolutions is for the most part
`to
`preparations of a solid, a liquid, and less Irequently
`a gassolute dissolved in a liquid solvent.
`In pharmaceutical terms. solutions are "liquid
`preparations that contain one or more chemical
`substances dissolved in a suitable solvent or mix-
`
`ture of mutually miscible solvents" (1}.Be-cause ota
`particular pharmaceutical solutiorrs use, it may be-
`classitied as an erelsolnticrl. atic solution, ophthalmic
`solution, or topll solution. Still other solutions, ‘be-
`cause of their composition oruse, maybeclassified
`as other phmzrnaceuticel dosage forms. For exam-
`ple. aqueous solutions containing a sugar are clas-
`sified assynqtrs; sweetened hyclroalcaholie (combi-
`nations ofwater and ethanol} solutions are termed
`eliiciw; solutions of aromatic materials" are termed
`spirits if the solve-ntis alcoholicor erontaticwctersif
`the solvent is aqueous. Solutions prepared by ex-
`tracting active constituents from crude drugs are.
`termed tinctures orfiuid ertreda. dependingon their
`method of preparation and their concentration.
`Iincturm may take be solutions of chemical aub-
`stsnoes dissolved in.-alcohol or in a lryclroalcoholic
`solvent. Certainsolutions prepared tobesterileand
`pyrogen-free and intended for parenteral adminis-
`tration are classified as
`Although other
`eararnples could be- cited, it is apparent that nsolu-
`ticrn, as a distinct type‘ of pharmaceutical prepara-
`tion, is rrmch further defined than is the physics-
`chernical definition of the term salvlion.
`Oral solutions. Sffrups, elixirs, spirits and tinc-
`lures are prepared and used tor the specific effects
`of the
`agents present. In these prepara-
`tions, the medicinal agents are intended to provide
`
`systemic eiieets.'I‘he fact that they areadrninisteted
`in solution form usually means that their absorp-
`lion from the gastrointestinal tract into the sys-
`temic circulation maybe expectedtooccur more
`rapidlyflianfromsuspensionorsoliddosage forms
`of the same rrtedicinal agent.
`Solutes other than the medicinal agent are usu-
`allypresent in orally
`solutions.T_h.ese
`aadditional agents usually are included to
`color, flavor, sweetness, or stability to the solution.
`In formulating -or compounding la phamiaceulical
`solution, the pharntadst must utilize inionnation
`on the solubility and stability of each of the solutes
`prment with regard to the solvent or solvent sys-
`tem employed Combinations of medicinal or
`pharrrraceulic agenls that will result in Chcrnical or
`physical interactions attesting the therapeutic qual-
`ityorphannaceulicstahilityofthe product mustbe
`avoided.
`For 5'ingle—solute solutions and especially for
`multiple-solute solutions, the pharmacist must be
`aware of the solubility characteristics of the solutes
`and the features of the common pharrnaceufical
`solverus. Each chemical agent has its own solubil-
`ity in a given solvent. For marry medicinal agents-,.
`their solubilities in the usual solvents are stated in
`the USP aswellas in elite: referencebool-ts.
`
`"Solubility
`Attractive forcesbetween ahornsleadtothe for-
`mation of molecules and ions. The lntenr1ol'ecula.t
`forces, which are developed between like mole—
`cules, are responsible for the physical state (i.e-.,
`solid, liquid, or gas} of the substance under‘ given
`conditions, as temperature and pressure-.Under or-
`dinary conditions, most organic compounds, and
`thus most drug substances, form molecularsolids.
`Wher1mo1eculesinteract,attractiveforoesa.rv.'lre-
`pulsive£orcesareinefl‘ect.The attract-Iveforcescause
`the molecules to cc-here, whereas the repulsive
`
`Astraleneca Ex. 2096 p. 6
`
`

`
`198
`
`Solutions
`
`fioroes pretrent molecular mterpenetration and. de-
`struction. When the attractive and repulsive forces
`areequaL the potential energyhetweentwooto1e—
`culesisminimumandthesystemismoststable.
`Dipolar molecules firequently tend to- aligra
`themselves with other dipole: molecules such that
`the negative pole of one molecule points toward
`the positive pole of the other. Large groups of mol—
`ecules may be associated through. these weal: at-
`tractions known as dipole-dipole or van do" Waals
`foroesln addition. to the dipolarintecaclions. other
`attntctions OCCI.1J.'bEtW'¢E1'l polar and nonpolar mol-
`ecules and ions. The include ion-dipole forces-
`and hydrogen bonding. The latter is of particular
`interest. Because of small size and large electrosta-
`ticfield. the hydrogen atom canrnovein closetoan
`electronegative atom. forming an electrostafic type
`of association referred to as a hydrogen bond or hy-
`drasen bridge Hydrogen bonding involves strand!
`electronegative atoms as cmygven, nitrogen. andflu-
`orine. Such a bond exists in water, represented by
`the dotted lines:
`
`pagan‘
`H/0¥\l-Iwflafl/oxfl
`
`Hydrogen bonds also most between some alcohol
`molecules, esters. carboxylic acids, aldehydes, and
`polypeptides.
`When asolute dissolves, the substance’s inter-
`molecular forces of aflzraction must be overcome by
`forces of attraction between the solute and solvent
`
`molecules.'I‘hts involves breaking the solute-solute
`forces and the solvent-solvent forces to achieve the
`solute-solvent attraction.
`
`The solubility of an agent in a particular “solvent
`indicates the maximum concentration to which a
`
`solution may beprepared with that agent and that
`‘solvent. When a solvent, at -it given temperature,
`hasdissolvedallof the solute it can, itis saidtobe
`saturated. To emphasize the pos_s1'ble variation in
`solubility between two chemical agents and there-
`forein the amounts ofeach required to prepare a
`saturated solution. two oficial aqueous. saturated
`solutions are cited as examples. Calcium Hydroxide
`'E)pical Solution, USP, and Potassium Iodide Oral
`Solution. USP. The first solution. prepared by agi-
`
`tating an excess arnounr of calcium hydroxide with
`purified water. contains only about 140 mg of dis-
`solved solute per 1.0!} 1:111. of sol1_.:tio_n.at 25°C,
`whereas the latter solution contains about 100 g of
`solute per 100 ml. ofsolution, over 700 t‘nnes.as
`much solute as
`in the calcium hydroxide
`topical solution. it is apparent from this compari-
`son that the rnaximurn possible concentration to
`which a phamlaciat may prepare a solution varies
`greatly and is dependent. in part. on the chemical
`constitution of the solute. Through selection. of a
`diffiexent solubilizing agent or a difierent chemical
`salt EDEEI1 of the medicinal agent, alteration of the
`pH ofa solution, or substitution. in part or in whole,
`ofthesolvent, apharmadstceninceflain instances
`dissolve g-eater-q1.1sntities of a solute than would
`otherwise be possible. For example, iodine gran-
`ules are soluble in water only to the extent of ‘I g
`In about 3000 ml. of water. Using only these
`two agents. the maximum concentration possible
`would be approximately D.tJ3% of iodine in aque-
`oussolution.l-lowever. tl1tt}ugh'the use ofan aque-
`ous solution of potassium or sodium iodide as the
`solvent, much larger amounts otiodirte may be dis—
`solved as the result of the formation of a water-
`
`soluble complex with the iodide salt.Tbis reaction
`is taken advantage of, for example, in Iodine Topi-
`cal Solution, USP, prepared to contain about 2% of
`iodine and 2.4% of sodium iodide.
`
`Temperature is an important factor in determin-
`ing the solubility ofa drugand inpreparing its so—
`lution. Most chemicals absorb hear when they are
`dissohtedand are said to have apositfce heal‘ ofs'o-
`lsrtifltl. resulting in increased solubility with an in-
`crease in tem:perature.A few chemlcalshave snag»
`eons hear of solution and exhibit -a decrease in
`solubility with a rise In lierrlperstute. Other factors,
`in addition to ternperattire, a.EEec1_: sol_ubillty.'I'hese
`include the various chemical and other physical
`properties ofboth the solute and the solvent, fic-
`tors of pressure, the acidity“ or basicity-of the solu-
`tion, the state ofsubdivlsion of the solute, and the
`physical agitation applied to the solution during
`the dissolving process. The solubility of a pure
`chemical substance at 3 given temperature and
`pressure is oorlstalllii however, its rate qf solution,
`thatis. the speedatwhichit dissolves, depenclson
`thepatticleslze ofttresubetanceandtheextentof
`agitation.'I'l1e finer the powder. the greater the sur-
`face area that comes in contact with the solvent-,.
`andthe more rapidthedissolvingprocess.Also, the
`greater die sgitatiora, the more unsaturated solvent
`passes over the drug, and the faster the formation
`of the solution.
`
`Astraleneca Ex. 2096 p. '7
`
`

`
`Tltesolubilityofasubstanoeinaglvensolvertt
`may be deterrnined by preparing a saturated solu-
`tion ofitet aspecific temperature andcletermining
`bychetnical analysis the
`oichcmical dis-
`solved in a given weight of solution. By simple cal-
`culation, the amount of solvent requiredto dissolve
`the amount of solute can be determined. The solu-
`bility may then be expressed as grams ofsolule disr
`solvingin roilliliters ofsolvent—t'or examplefl got
`sodium chloride dissolves in 2.8 ml. of water.‘
`When theexactsohibilityhssnot been determined,
`general expressions of relative solubility may be
`LL-sed."Ihese terms are defined fir the USP as pre-
`sented inTahIe 12.1 (2).
`Agreatmanyofthe important orgsnicmeclicinal
`agents are either weak acids or weak bases, and
`their solubility is-dependent to a large measure on
`thepH of fire solve'nt.'i'l-iese drugs react either 'Wlfh
`strong acids -or strong bases to form water-soluble
`salts. For instance, Ehe weak bases, includingmany
`of the alkaloids (atropine, codeine, rand niotphine),
`antihistamines (dnahenyhydrarnine and tu‘pelen-
`namlne], local anesthetics (cocaine, procaine, and
`tetracaine), and otherirnportanl drugs are not very
`water-soluble, but they are soluble in dilute solu-
`tions oi
`manufacturers have
`prepared manyacidsalts ofthese organic bases to
`enable the preparation of aqueous solutions It
`must be recognized, however. that if the pH of the
`aqueous solutions of these salts is changed by the
`addition of alkali, the free base may separate from
`solufion unless it has adequate solubilltyin water.
`Organic tnedicinals that are weak acids
`the
`barbiturate drugs (as phenobarbital and pentobar-
`bital) and the sulfonarnides (as sulfadiazine and
`sulfacetan1ide).These and other weak acids form
`waler—soluble salts in basic solution and maysepa-
`rate from solution by a lowering of the pH. ‘Fable
`1512 presents the comparative solubilities of sortie
`typical examples ofweak adds and weakhascs and
`their salts.
`
`Table 12.1. Relative Terms of Solubility {II
`
`Drsoiptivciirnn
`Very soluble
`Freely soluble
`Soluble
`Spatingiy -soluble
`Slightlysoluble
`Very slightly soluble
`Practically insoluble
`or tnsoluhle
`
`Parts ofsofimrl Rsqzurcd
`for1Htr£o[Sahrte
`Less than 1
`From 1 to 10
`From in to as
`From 30 to 100
`From 1.00 to 1000
`Fmm 100010 1o,mc
`10.000 and over
`
`'SalufimS
`
`199
`
`Table 122. Water a.nd'Aloohol Snlnhilities of Some
`Selected Weak Acids, Weak lilies, and Their Salts
`
`Number q,FmL of'SalDent
`Request to Dissalw
`I so‘We
`Alcohol
`
`Water
`
`455
`0.5
`120
`an
`2.5
`5,000
`16
`1,000
`1
`200
`1
`13.000
`2
`
`2'
`5
`2
`1,280
`325
`2-10
`5
`
`B
`10
`soluble
`15
`sparingly soluble
`slightly soluble
`
`Drug
`
`Atropine
`Atropine sulfate
`Codeine
`-Codeine sullate
`Codeine phosphate
`Morphine
`Morphine sulfate
`P1-renobarbital
`Phenobarbital sodium
`Ptocaine
`Procaine hydrochloride
`Sulladiaxlrur
`Sodium-sulfadiazinc
`
`Although there are no exact rules" for predicting
`unerringlythesolubilltyofa chemical agent ins
`particular
`liquid, experienced pharmaceutical
`chemists can estimate the general solubility ofa
`chemical compound based on its molecular struc-
`ture and functional groups.The infiormation gath-
`ered on a great number of individual chemical
`compounds has led to the characterization of the
`solubilities of groups of compounds, and though
`there may be an occasional inaccuracy with respect
`to an individual member of a group of compounds,
`the generalizations nonetheless serve a useful
`function.Asclen1onstratedbythedata in'Ii«1ble 12.2
`and other similar data, salts of organic compounds
`are more soluble in water than are the correspond-
`ingorganic bases. Conversely, the organicbases are
`more soluble in organic solvents,
`than are the corresponding salt forms. Perhaps the
`most written guideline for the prediction ofso1u-
`bilityis I:hal"l:1ce dissolves lil:e,"meam‘n glhat-a sol-
`vent having a chemical mucture most similar In
`tl1atof.tl"(e irlmrlded solutewillbc most likely to
`dissolve it.Thus, organic compounds are more sol-
`ublein organirzsolvcnts thaninwater. Organic
`compounds may, however.‘ be somewhat water-
`soluble if they contain polar groups capable of
`fanning hydrogen bonds with wate1_'.l.n fact. the
`greater the number of polar groups present. the
`greater will likely be the organic compound’: solu-
`bility in water. Polar groups include 0H. CH0,
`COH» CHOH. Cl-I3CIH, C001-I, N01, C0, NH,’
`and S031-I.'l'hc introduction ofhalogen atoms into
`
`Astraleneca Ex. 2096 p. 8
`
`

`
`3011
`
`Solutions
`
`a molecule tends to decrease wster—solubil:lty be-
`cause of an increase in the molecular weight of the
`compotuicl without aproportionate increase. in po-
`1arity.Aninctc-sse inthc molecular weight of an or-
`ganic compound without a change in polarity re-
`sults in decreased solubility in water. Table 12.3
`demonstrates some of these generalities through
`the use of specific chemical examples.
`As with organic compounds, the pharmacist is
`aware of some general patterns of solubility that
`apply to inorganic compounds. For instance. most
`salts of rnonovalent cations such as sodium, potas-
`sium,-. and ammonium are water soluble, whereas‘
`the divalent cations like calcium, magnesium, and
`barium usually form water-soluble compounds
`with nitrate, acetate, and chloride anions but not
`with carbonate. phosphate, or hydrozdcle anions. ‘R:
`be sure. there are certain corubinnfions of anion
`and cation that would seem to be similar in make-
`
`up but that do nothave similar solubility character-
`istics. For instance, magnesiumsulfate (Epsomsalt)
`is soluble, but calcium sulfate is only slightly solu-
`ble; barium sulfite isveryinsoluble (1 gdissolves in
`about 400,000 mi. of water) and is used as an
`opaque media for x-ray observation of the intesti-
`nal tract, but barium sulfide and barium sulfite are
`notasinsoluble,andtheirora1usecanresu1tmpoi-
`sorting; mercurous chloride Cl-_IgCl} is insoluble and
`mass Eonnerly used as a cathartic, but mercuric chlo-
`ride (HgCL_,) is solublein waterandisa deadly/poi-
`son if taken lntema1l'y.'l'11ere are many instances in
`which solubilities of certain drugs and their differ-
`entlstioniromotlzietdnlgs are criticalto tl.'lE‘pl’liIl‘-
`macist in order that he or she might avoid com-
`pounding failures or therapeutic disasters.
`
`Table 12-3. Solubilities of Selected Organic
`Compounds in Water as at Demonstration of
`Chemical Structure-Solubility Relationship
`
`Compound
`Benzene
`Benzoic acid
`Benzyl alcohol
`Phenol
`P-.vr°'=Ab=c'h°|
`Flwsallul
`Carbon tetrachloride
`Chloroform
`Methylene chloride
`
`Formzda
`QH.
`C5!-_l,CCl0H
`C,H,CH3OH
`C,.}-I501-I
`CeH4(01'D2
`CsHz(°H3a
`CCI,
`CHCI5
`Cl-I301
`
`Number ofmi.
`oflvflrtcr
`Required to
`Dissolve 1 gof
`Compound
`1430
`2?5
`25
`15
`33
`17
`2,000
`200
`50
`
`For organic as well as for inorgarnic solutes. the
`ability of a solvent to dissolve them depends on
`its effectiveness in overcoming the electronic
`forces that hold the atoms of the solute together
`and the corresponding lack of resolute on the
`part of the ll'.10_11:I3 themselves to resist the -solvent
`action. During the dissolution process, the mole-
`cules of the solvent and the solute become
`
`uniformly mixed and cohesive forces of the atoms-
`are replaced by new forces due to the attraction
`of the solute and solvent molecules for one
`another.
`
`The student may find the following geneusl rules
`of solubility useful.
`
`Inorgrmic Molecules
`1. lfboll:thecationartdanionofanionicoom-
`pound are momoalsnt, the solute-solute attrac-
`tive form are usually easily overcome, and
`therefore, these oompounds are generally water
`soluble. (Examples, Nacl, Liar, 1:1, memo,
`NaNO,)
`2. IEonlyoneofthetwoio'nsinanionicoom-
`pound is
`the solute-solute interac-
`tions are also usually easily overcome and the
`compounds -are water soluble.
`(Examples:
`Ba‘-‘la: M812: N92504: NasP04J
`3. Ifboth the cationand anionare multiuclenr, the
`solttte—solui:e interaction maybe too great to be-
`overcome by the solute-solvent interaction
`and the compound may have poor water solu-
`bility. (Examples: CaSO‘, BaSCl,,, BiP0,; Ex-
`ceptions: ZnSO.,, F950,)
`4. Comrnonsalts ofalkalimetals (Na,K,I..i, Cs,
`Rb) are usually water soluble.
`(Exception:
`I-ECO.-J
`S. Ammonium and quaternary ammortium salts
`are water soluble.
`l‘\l‘tl:rates, nitrites, acetates, chlorates, and tan-
`tates are generally water soluble. (Exceptions:
`silver and mercurous acetate)
`7. Sulhtes, gulfites, and thlosulfates are generally
`water soluble. (Exceptions: calcimn and bar-
`ium salts)
`8. Chloridtrs, bromides, and iodidm are water
`soluble. (finceptionszz salts of silver and mer-
`curousions)
`9. Acid salts corresponding to an insoluble salt
`will be more water soluble than the original
`salt.
`
`I5.
`
`10. I-lydroxidea and oxides of compounds other
`llzart alkali metal cations and the antmonium
`
`generally water insoluble.
`
`Astraleneca Ex. 2096 p. 9
`
`

`
`Solutions
`
`301
`
`11. Sulfides are water insoluble except for their
`alkali metal salts.
`
`12.
`
`carbonates, silicates, isolates, and
`hypochlofites are water insoluble except for
`their alkali metal salts and amrnortium salts.
`
`Some Solvents For
`
`Liquid Preparations
`
`Thefollowing agents linclusesssolventsin the
`preparation of solutlorrs.
`
`Organs‘: Molecules
`
`‘.l. Molecules having one pole: functional group
`are usually soluble to total chainlengths of Eve
`carbons.
`'
`2. Molecules having branched chains are more
`soluble than the corresponding straight-chain
`compound.
`3. Meter solubility decreases wiflr an increase in
`molecular weight.
`4. Increased structural sirnilarity between solute
`and solvent is aoootnpsnied by increased solu-
`bility.
`
`It is the pharmocisfs lrnowledge of the chemical
`characteristics ofdrugs that permits the selection of
`the proper solvent Eoraparticularsolutel-lowevet.
`in addition to the factors of solulbility. the selection
`is based on such additional solvent characteristics
`
`as clarity, low tO'.\ClCl'l.'fi viscosity. cornpalibility with
`other fotmulafive ingredients. chemical inertness.
`palatability. odor. color, and economy. In most in»
`stances, and especially for solutions to be taken
`orally, used ophthalmically, or injected, wateris the
`preferred solvent because it comes closer to meet-
`ing the ntajority of the above criteria than the other
`available solvents. In many instances, when water
`is used as the primary solvent, an aurdliary solvent
`is also employed to augment the solvent action of
`water or to contribute to a product’s chemical or
`physical stability. Alcohol, glycerin. and propylene
`glycol, perhaps the most used auxiliary solvents,
`have been quite efiective in contributing to the de-
`sired characteristics of pharmaceutical solutions
`and in maintaining their stability.
`Other solvents, such as acetone. ethyl or-tide, and
`isopropyl alcohol. are too tordc to be permitted" in
`phannaceutical preparations to be taken intanally.
`buttheyareusefulasreagerusolvenlsinorganlc
`cherrristry anclin the preparatorysiages of drug de-
`velopment, asin the exlracfionorrernoval ofactive
`-oorestinlents from medicinal plants. For purposes
`such asthis. certatnaolvents are officiallyrecognlzed
`lnthecompendla.Anurnbero£fixedoils,sI.tchas
`oomoil, oottorrseedofl, peanutoil, andsesatne-oil,
`serve useful solvent functions particularly in the
`preparation of oleaginous injections -and are recog-
`nlmedin the offidalcompendla Eorthis purpose.
`
`Alcohol. IISP (Ethyl Alcohol,
`Ethanol, C,H50H)
`Next to water alcohol is the most useful solvent
`inpharrr1acy.ItisusedassprimarysolventEo1'
`many" organic compounds. Together with water it
`forms a ltydroalooholic mixttrre that dissolves both
`alcohol-soluble and water-soluble substances, a
`feature pecially useful in the extraction of active
`constituents from crude drugs. Byvarying the pro-
`portion of the two agents, the active constituents
`may be selectively dissolved and attracted or al-
`lowed to remain behind according to their particu-
`lar solubility characteristics in the menslruum. Al-
`-cohol. USE is 94.9 to 96.0% C21-I501-I by volume
`(i.e.. vhr) when deliermined at l5.56“C_, the U.S.
`Government's standard temperature fior alcohol
`detenninatlons. Dehydrated Alcohol. USE contains
`not less than 99.5% CAI-l50H byvohtme and is uti-
`lizedininstancesinwhichan essentially water-free
`alcohol is desired.
`
`Alcohol has been well recognized as a solvent
`and encipient in the formulation of oral phonon-
`ceutical products. Certain drugs are insoluble in
`water and must be dissolved in an alternate vehi-
`cle. Alcohol is often preferred because of its misci-
`bility with water and its ability to dissolve roam?
`waier—insolubIe ingredients, including drug sub-
`stanoes,i1avorants,eud antimicrobial preservatives.
`Alcohol Is frequently used with other solvents, as
`glycol: and glycerin. to reduce the amount of alco-
`hol required. It also isusedin liquid products as an
`antimicrobial preservative alone one a copreserv-
`arise with paflbens, benzaoatest sorbatm, and other
`agents.
`However, aside from its pharmaceutic advan-
`tages as a solvent and preservative, concern has
`been expressed over the undesired phannaeologic
`andpotentlal toxic effects ofalooholwheningested
`in phannaceutical products particularly by child-
`ren.Thus, the FDA has proposed that manufactur-
`ers of OTC -oral drug products restrict, insofar
`as possible, the use of alcohol and include appro-
`priate warnings in the labeling. For OTC oral prod-
`ucts intended for children under 6 years of age. the
`recommended alcohol-content limit is 0.5%; fior
`products intended for children 6 to 12 years of age,
`the recommended l‘uru‘t is 5%; and for products
`
`Astraleneca Ex. 2096 p. 10
`
`

`
`392.
`
`Soiutiolts
`
`Ireuommendedfornhildxen over123/ears ofsgesnd
`for acl1.Il1s,'the recommended limit is 10%-
`
`Diluted Alcohol, NP
`
`Diluted .Alcol'1ol.NF, is prepared by'I:cu'xir\g equal
`volumes of Alcohol. USB and Purified VVatel'. USE‘.
`The finalvohinte cci-suchrnixturesisnotthesurn of
`the individual irolumesof the two components, but
`duenooontraction oitheliquirkupon mixir|g,tl-1e fi«
`nalvolumeis gerrerullyab0'ut39b1essthanw'hut
`would normally be expected. Thus when 50 mt. oi
`each component "is combined, the resulting product
`measures approximately 97 mi... It is for this reason
`that the strength of Diluted Alcohol, NE is not ex-
`actlyhalfthat ofthe more concentrated alcohol, but
`slightly greater: 1PP“3'X5n'|ateI}' 4996. Diluted alcohol
`is a useful ltyllroalcoholic solvent in various phar-
`maceutical processes and preparations.
`
`Aicatwl, Rubbing
`
`Rublririgiklcohol contains about 70% ofethyl el-
`coho! by volume, the remainder consisting ofwu—
`ter, denaturantswith orwitiiout color additives and
`perfume oils, and stabilizers. In each 100 ml.., it
`must contain not less than 355 mg of sucrose oc-
`taacetate or 1.4 mg of denatonium benzoate, bitter
`substances that discourage accidental or abusive
`oral ingestion. The dsnahirants employed in rub-
`bing alcohol are according to the Internal Revenue
`Service, US». Treasure Department, Formula 23-I-I,
`which iscomposed of 8 parts byvotume of acetone,
`1.5 parts byvolurne of:nethy1isobutyllr.etone,sr|_d
`100 parts byvolume of ethyl alcoholfllie use otthis
`denaturant mixture makes the separation of ethyl
`alcohol from -the denahirants avirtually itnpossible
`task with ordinary distillation apparatus. This dis-
`courages the illegal removal and use as a beverage
`of the alcoholic content of rubbing alcohol.
`The productisvolatile and flammable and should
`be stored in tight oontairrers nemote from Ere. It is
`employeclas anibefacient extemsilyand asa sooth-
`ing mb for bedfidden-patiems, agennicide tor in-
`struments. andaslcin cleanserptiortoinjection. Iris
`3150135211 asavehiclefortopicalpreparafions.
`Synonym: Alcohol Rubbing Compound-
`
`GI-year-in, IISP {GIyceraI):
`CH3.OH- CHOH' C'H2_OH
`
`Glycerin is it clear syrupy liquid with a sweet
`taste, It is miscflzlle both with waterand alcohol. As
`a sohrent, it is comparable with alcohol, but because
`
`of ilsvisoosity, solutesare slowtysotuble initunless»
`it is tenderer! lm viscous hyheefing. Glycerin has‘;
`preservative qualifies and is often used as a stabs.
`lizerandas an auxiliary solventin conjunction with.
`watetora1oohDLItisusedinmanyintemal prepay:
`rations.
`
`Isapropyl R-ulJbingAlcoiro!
`
`lsopropyl Rubbingfilccd-tol is about 70% by-val.
`urns isopropyl-alcohol. the remainder consisting of
`water with or without color additives. stabilizers,
`and perfurne oils. It is used'e>'ctemel1y as a rubetas
`dart and sootl1i.ng.rub and as a vehicle for topical
`products. This preparation and a commercially
`available 91% isopropyl alcohol solution are com-
`monly employed by diabetic patients in preparing
`needles and
`fiorhypodennic injections of
`
`1nsuJ1n'' and to: disinfecting the skin.
`
`Propylene Glycol, USP,
`ch,cH(0rDcH,oH
`
`Propylene glycol, a viscous liquid, is miscible
`with water and aloo11oI.1t is a useful solvent with a
`
`wide range ofapplications and is frequently substi-
`tuted for glycerin in modern pharmaceutical for-
`mulations.
`
`Purified Water, use, H20
`
`Naturallyoucuningwaterexertsitssolvent ei3FEC‘l’
`on most substances it contacts and thus is-impure
`and contains varying amounts of dissolved inor-
`prlic salts, usually sodium. potassium, calcium,
`magnesium, and iron, chlorides, sulfates, and bi-
`carbonates, as well as dissolved and undisrolved
`organic matter and microorganisms. Water found
`inmost cities andtowns where water is-purified for
`diinltingpiri-poses usually contains less than 0.1%
`oftotal solids, delnennined by evaporatinga 100 mL
`ample of water to dryness and weighing the
`residue {which would weigh less than 100' mg).
`Drinking water must meet the United States Pub-
`lic Health Service regulations with respect to bac-
`tcrioiogical purity. Acceptable dfinldng water
`should be clear, colorless. odorless, and neutral or
`only slightly acid or alkaline, the deviation from
`ncutral'bei:ttgdueto tlienatureofthedissolved
`solids and gases [carbon dioxide r.onn:ibutingto.the
`eciditysnd arrrrnonia to the sllrali

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket